AngioDynamics (NSDQ:ANGO) shares ticked up this morning on fourth-quarter results that beat the consensus revenue forecast. The Latham, N.Y.-based peripheral artery disease (PAD) treatment developer posted losses of -$19.5 million, or -51¢ per share, on sales of $76.8 million for the three months ended May 31, 2021, for an 87.6% bottom-line gain … [Read more...] about AngioDynamics rises on Street-beating Q4 revenues
AngioDynamics
AngioDynamics mechanical thrombectomy system wins FDA clearance
AngioDynamics (NSDQ:ANGO) today said it received FDA 510(k) clearance for its AlphaVac mechanical thrombectomy system. AlphaVac is an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. Latham, N.Y.-based AngioDynamics designed the system with a … [Read more...] about AngioDynamics mechanical thrombectomy system wins FDA clearance
Medline Industries buys Namic business from AngioDynamics
Medline Industries will pay $167.5 million to acquire the Namic fluid management business from AngioDynamics (NSDQ:ANGO), the companies announced today. The deal, subject to customary closing conditions, is expected to close in the summer. It will allow Medline to acquire the manifolds, contrast management systems, closed fluid systems, … [Read more...] about Medline Industries buys Namic business from AngioDynamics
